CD47-mediated regulation of glucose and lipid metabolism: implications for the pathogenesis of MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), has gradually become a leading cause of end-stage liver disease as a heterogeneous group of diseases. While the underlying mechanisms of MASLD remain incompletely understo...
Saved in:
| Main Authors: | Xinru Jiang, Wei Zhao, Botao Shen, Yumeng Han, Kexin Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1535382/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MASLD: insights on the role of folate in hepatic lipid metabolism
by: Minlan Yang, et al.
Published: (2025-07-01) -
Research progress on AMPK in the pathogenesis and treatment of MASLD
by: Jiang Feng, et al.
Published: (2025-03-01) -
HIIT versus MICT in MASLD: mechanisms mediated by gut-liver axis crosstalk, mitochondrial dynamics remodeling, and adipokine signaling attenuation
by: Dongkun Deng, et al.
Published: (2025-04-01) -
Correlation between chronic low-grade inflammation and glucose and lipid metabolism indicators in polycystic ovary syndrome
by: Yan Zhou, et al.
Published: (2024-12-01) -
Immunotherapeutic Blockade of CD47 Increases Virus Neutralization Antibodies
by: Lamin B. Cham, et al.
Published: (2025-05-01)